lerodalcibep
General
Pronunciation:
ler-oh-dal-si-bep
Trade Name(s)
- Lerochol
Ther. Class.
lipid-lowering agents
Pharm. Class.
proprotein convertase subtilisin kexin type9 pcsk9 inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Lerodalcibep." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580204/all/lerodalcibep.
Vallerand AHA, Sanoski CAC. Lerodalcibep. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580204/all/lerodalcibep. Accessed October 23, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Lerodalcibep. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580204/all/lerodalcibep
Vallerand AHA, Sanoski CAC. Lerodalcibep [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 23]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580204/all/lerodalcibep.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lerodalcibep
ID - 3580204
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580204/all/lerodalcibep
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -

Davis's Drug Guide

